These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11967261)

  • 1. Cell surface accumulation of a truncated transmembrane prion protein in Gerstmann-Straussler-Scheinker disease P102L.
    Mishra RS; Gu Y; Bose S; Verghese S; Kalepu S; Singh N
    J Biol Chem; 2002 Jul; 277(27):24554-61. PubMed ID: 11967261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic origin of protease-sensitive and protease-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease with the P102L mutation.
    Monaco S; Fiorini M; Farinazzo A; Ferrari S; Gelati M; Piccardo P; Zanusso G; Ghetti B
    PLoS One; 2012; 7(2):e32382. PubMed ID: 22384235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS.
    Asante EA; Grimshaw A; Smidak M; Jakubcova T; Tomlinson A; Jeelani A; Hamdan S; Powell C; Joiner S; Linehan JM; Brandner S; Wadsworth JD; Collinge J
    PLoS Pathog; 2015 Jul; 11(7):e1004953. PubMed ID: 26135918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inherited prion disease A117V is not simply a proteinopathy but produces prions transmissible to transgenic mice expressing homologous prion protein.
    Asante EA; Linehan JM; Smidak M; Tomlinson A; Grimshaw A; Jeelani A; Jakubcova T; Hamdan S; Powell C; Brandner S; Wadsworth JD; Collinge J
    PLoS Pathog; 2013; 9(9):e1003643. PubMed ID: 24086135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Gerstmann-Sträussler-Scheinker disease mutation defines a precursor for amyloidogenic 8 kDa PrP fragments and reveals N-terminal structural changes shared by other GSS alleles.
    Mercer RCC; Daude N; Dorosh L; Fu ZL; Mays CE; Gapeshina H; Wohlgemuth SL; Acevedo-Morantes CY; Yang J; Cashman NR; Coulthart MB; Pearson DM; Joseph JT; Wille H; Safar JG; Jansen GH; Stepanova M; Sykes BD; Westaway D
    PLoS Pathog; 2018 Jan; 14(1):e1006826. PubMed ID: 29338055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small ruminant nor98 prions share biochemical features with human gerstmann-sträussler-scheinker disease and variably protease-sensitive prionopathy.
    Pirisinu L; Nonno R; Esposito E; Benestad SL; Gambetti P; Agrimi U; Zou WQ
    PLoS One; 2013; 8(6):e66405. PubMed ID: 23826096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards authentic transgenic mouse models of heritable PrP prion diseases.
    Watts JC; Giles K; Bourkas ME; Patel S; Oehler A; Gavidia M; Bhardwaj S; Lee J; Prusiner SB
    Acta Neuropathol; 2016 Oct; 132(4):593-610. PubMed ID: 27350609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Anchorless Human PrP With Q227X Stop Mutation Linked to Gerstmann-Sträussler-Scheinker Syndrome In Vivo and In Vitro.
    Shen P; Dang J; Wang Z; Zhang W; Yuan J; Lang Y; Ding M; Mitchell M; Kong Q; Feng J; Rozemuller AJM; Cui L; Petersen RB; Zou WQ
    Mol Neurobiol; 2021 Jan; 58(1):21-33. PubMed ID: 32889654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.
    Tremblay P; Ball HL; Kaneko K; Groth D; Hegde RS; Cohen FE; DeArmond SJ; Prusiner SB; Safar JG
    J Virol; 2004 Feb; 78(4):2088-99. PubMed ID: 14747574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous generation of infectious prion disease in transgenic mice.
    Torres JM; Castilla J; Pintado B; Gutiérrez-Adan A; Andréoletti O; Aguilar-Calvo P; Arroba AI; Parra-Arrondo B; Ferrer I; Manzanares J; Espinosa JC
    Emerg Infect Dis; 2013 Dec; 19(12):1938-47. PubMed ID: 24274622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice.
    Nazor KE; Kuhn F; Seward T; Green M; Zwald D; Pürro M; Schmid J; Biffiger K; Power AM; Oesch B; Raeber AJ; Telling GC
    EMBO J; 2005 Jul; 24(13):2472-80. PubMed ID: 15962001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel PRNP-P105S mutation associated with atypical prion disease and a rare PrPSc conformation.
    Tunnell E; Wollman R; Mallik S; Cortes CJ; Dearmond SJ; Mastrianni JA
    Neurology; 2008 Oct; 71(18):1431-8. PubMed ID: 18955686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gerstmann-Sträussler-Scheinker: a new phenotype with 'curly' PrP deposits.
    Colucci M; Moleres FJ; Xie ZL; Ray-Chaudhury A; Gutti S; Butefisch CM; Cervenakova L; Wang W; Goldfarb LG; Kong Q; Ghetti B; Chen SG; Gambetti P
    J Neuropathol Exp Neurol; 2006 Jul; 65(7):642-51. PubMed ID: 16825951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations.
    Piccardo P; Liepnieks JJ; William A; Dlouhy SR; Farlow MR; Young K; Nochlin D; Bird TD; Nixon RR; Ball MJ; DeCarli C; Bugiani O; Tagliavini F; Benson MD; Ghetti B
    Am J Pathol; 2001 Jun; 158(6):2201-7. PubMed ID: 11395398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxic and gliotrophic activity of a synthetic peptide homologous to Gerstmann-Sträussler-Scheinker disease amyloid protein.
    Fioriti L; Angeretti N; Colombo L; De Luigi A; Colombo A; Manzoni C; Morbin M; Tagliavini F; Salmona M; Chiesa R; Forloni G
    J Neurosci; 2007 Feb; 27(7):1576-83. PubMed ID: 17301166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease.
    Parchi P; Chen SG; Brown P; Zou W; Capellari S; Budka H; Hainfellner J; Reyes PF; Golden GT; Hauw JJ; Gajdusek DC; Gambetti P
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8322-7. PubMed ID: 9653185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein.
    Wadsworth JD; Joiner S; Linehan JM; Cooper S; Powell C; Mallinson G; Buckell J; Gowland I; Asante EA; Budka H; Brandner S; Collinge J
    Brain; 2006 Jun; 129(Pt 6):1557-69. PubMed ID: 16597650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gene-targeted mouse model of P102L Gerstmann-Sträussler-Scheinker syndrome.
    Barron RM; Manson JC
    Clin Lab Med; 2003 Mar; 23(1):161-73. PubMed ID: 12733430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein.
    Stewart RS; Piccardo P; Ghetti B; Harris DA
    J Neurosci; 2005 Mar; 25(13):3469-77. PubMed ID: 15800202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gerstmann-Sträussler-Scheinker disease subtypes efficiently transmit in bank voles as genuine prion diseases.
    Pirisinu L; Di Bari MA; D'Agostino C; Marcon S; Riccardi G; Poleggi A; Cohen ML; Appleby BS; Gambetti P; Ghetti B; Agrimi U; Nonno R
    Sci Rep; 2016 Feb; 6():20443. PubMed ID: 26841849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.